Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Discover how Angiotensin II orchestrates cellular regulation by directing the ubiquitin-proteasome pathway to degrade IP3 receptors, with implications for cardiovascular health.